7956
H. A. Dondas et al. / Tetrahedron 57 ꢀ2001) 7951±7964
1477, 1424, 1396, 1329, 1157, 1095, 825 and 755 cm21
.
1328, 1158, 1094, 825 and 753 cm21. m/z3%)327 3M1, 6),
244 36), 175 317), and 107 3100).
m/z3%) 418 3M1, 3), 241 319), 198 3100), 175 354) and
111383).
1.2.9. C-[2-220-Thienyl)ethenyl]-N-[22-40-chlorophenyl-
sulphonamido)ethyl]nitrone 228b). Obtained as colourless
needles from ethyl acetate 3797 mg, 86%), mp 172±1738C.
3Found: C, 48.5; H, 4.3; N, 7.5. C15H15ClN2O3S2 requires:
C, 48.6; H, 4.1; N, 7.6%); d: 3.423t, J5.1 Hz, 2H,
CH2NH), 3.94 3t, J5.0 Hz, 2H, CH2N1), 6.61 3m, 1H,
NH), 7.1±7.38 3m, 6H, 3£thiophene H, CHvCHvCH),
7.50 and 7.83 32£d, J8.5 Hz, ArH); nmax 3®lm): 3080 br,
CH), 16023C vN), 1569, 1473, 1324, 1161, 1132, 1093,
967 and 752cm 21. m/z3%)370 3M1, 16), 353 312), 260
343), 195 319), 175 357), 166 343), 150 391), 136 338), 121
334) and 111 3100).
1.2.4. C-2Phenyl)-N-[2-240-chlorophenylsulphonamido)-
ethyl]nitrone 218d). Obtained as colourless amorphous
solid, mp 149±1518C. 3Found: C, 52.2, H, 4.45; N, 8.1, S,
9.7. C15H15 N2O3ClS requires: C, 53.2, H, 4.45; N, 8.25, S,
9.45 %). HRMS: 338.0493. C15H15N2O3 requires: 338.0492;
d: 8.13d, 2H, J8.1 Hz, Ar±H), 7.73d, 2H, J8.1 Hz, Ar±
H), 7.353m, 5H, Ar±H), 6.48 3br, 1H, HCvN), 4.1 3m, 2H,
NCH2N), 3.65 3br, 1H, NH) and 3.413m, 2H, NCH2N).
m/z3%) 339 3M11, 100), 323 37), 218 311), 149 321), 91
325), 69 347), 57 356) and 43 340).
1.2.5.
C-24-Tri¯uoromethylphenyl)-N-[2-240-chloro-
1.2.10.
C-22-Thienyl)-N-[2-240-chlorophenylsulphona-
phenylsulphonamido)ethyl]nitrone 218e). Obtained as
colourless needles from ethyl acetate 3590 mg, 58%), mp
171±1728C. 3Found: C, 47.1; H, 3.6; N, 6.85; S, 7.8.
C16H14ClF3N2O3S requires: C, 47.25; H, 3.45; N, 6.9; S,
7.95%); d: 3.50 3q, J5.4 Hz, 2H, CH2NH), 4.10 3t,
J5.1 Hz, 2H, CH2N1), 5.923t, J5.4 Hz,1H, NH), 7.45
3m, 3H, CHvN112ArH) and 7.70±8.20 33£d, J8.0 Hz,
3£2H, ArH). nmax 3®lm): 31003br, CH), 15883CvN), 1475,
mido)ethyl]nitrone 228c). Obtained as colourless needles
from ethyl acetate 3604 mg, 70%)], mp 174±175.58C.
3Found: C, 45.15; H, 3.95; N, 7.85, S 18.5. C13H13ClN2O3S2
requires: C, 45.3; H, 3.8; N, 8.1, S 18.6 %); d: 3.47 3q,
J5.1 Hz, 2H, CH2NH), 4.08 3t, J5.1 Hz, 2H, CH2N1),
6.173m, 1H, NH), 7.15 3m, 1H, CHvNO) and 7.7±7.8 3m,
7H, thiophene H and ArH). nmax 3®lm): 3050 3br,CH), 1586
3CvN), 1476, 1335, 1161, 1093, 828 and 758 cm21. m/z3%)
344 3M1, 10), 174 329), 169 342), 152 323), 124 398) and 111
3100).
1422, 1325, 1174, 1160, 1133, 1095, 861 and 765 cm21
.
m/zꢀ%) 406 3M1, ,1), 186 3100), 175 343), 159 354) and
111 368).
1.2.11. C-[2-220-Furyl)ethenyl]-N-[2-240-chlorophenylsul-
phonamido)ethyl]nitrone 228d). Obtained as colourless
amorphous solid from ethyl acetate). [5 mmol scale
31.28 g, 72%)], mp 167±1688C. 3Found: C, 51.10; H, 4.5;
N, 7.7. C15H15ClN2O4S requires: C, 50.8; H, 4.3; N, 7.9%);
d: 340 3t, J5.0 Hz, 2H, CH2NH), 3.94 3t, J5.0 Hz, 2H,
CH2N1), 6.46 3m, 1H, CHvCHvCH),6.59 3m, 1H, furyl
H) and 7.45±7.9 3m, 8H, ArH, furyl H, and CHvN1); nmax
3®lm): 3080 3br, CH), 2800 3br), 1619 3CvN), 1578, 1475,
1324, 1203, 1160, 1131, 1091, 931 and 738 cm21. m/z3%)
356 3M1, 4), 354 3M1, 11), 175 333), 161 314), 150 314), 134
3100), 121 337) and 111 363).
1.2.6. C-24-Cyanophenyl)-N-[2-240-chlorophenylsulphona-
mido)ethyl]nitrone 218f). Obtained as colourless needles
from ethyl acetate 3309 mg, 34%), mp 149±1518C.
3Found: C, 52.55; H, 4.05; N, 11.4; S, 8.95. C16H14ClN3O3S
requires: C, 52.8; H, 3.9; N, 11.55; S, 8.8%); d: 3.49 3t,
J5.3 Hz, 2H, CH2NH), 4.13 3t, J5.0 Hz, 2H, CH2N1),
5.80 3t, J 5.8 Hz,1H, NH), 7.45 3m, 3H, CHvN112ArH)
and 7.70±8.25 33£d, J8.0 Hz, 3£2H, ArH). nmax 3®lm):
3250 3br, NH), 3084 3br, CH), 22283CvN), 1587 3CvN),
1475, 1426, 1324, 1157, 1096, 1085, 830 and 754cm21
.
m/z3%) 363 3M1, ,1), 217 311), 188 327), 175 355), 143
3100), 130 327) and 111 376).
1.2.12. C-22-Furyl)ethenyl]-N-[2-40-chlorophenylsulphona-
mido)ethyl]nitrone 228e). Obtained as colourless amor-
phous solid from ethyl acetate 3460 mg, 56%)], mp
143.5±1468C. 3Found: C, 47.3; H, 3.9; N, 8.45, S, 9.75.
C13H13ClN2O4S requires: C, 47.5; H, 4.0; N, 8.5, S,
9.75%); d: 3.47 3q, J5.4 Hz, 2H, CH2NH), 4.023t, J
5.1 Hz, 2H, CH2N1), 6.07 3t, J5.7 Hz, 1H, NH), 6.57
3m, 1H, furyl H) and 7.45±7.9 3m, 8H, ArH, furyl H, and
CHvN1); nmax 3®lm): 3080 3br, CH), 28003br), 1586
3CvN), 1478, 1332, 1225, 1158, 1085, 824 and
775 cm21. m/z3%) 330 3M1, 2), 328 3M1, 6), 175 324),
153 320), 125 320) and 108 3100).
1.2.7.
C-22-Phenylethenyl)-N-[2-240-chlorophenylsul-
phonamido)ethyl]nitrone 218g). Obtained as colourless
needles from ethyl acetate [1.5 mmol scale 3409 mg,
75%)], mp 186±1888C. 3Found: C, 56.1; H, 4.9; N, 7.95.
C17H17ClN2O3S requires: C, 56.0; H, 4.7; N, 7.7%); d
3DMSO-d6): 3.26 3t, J5.3 Hz, 2H, CH2NH), 3.48 3q, J
5.5 Hz, 2H, CH2N1) and 7.30±8.40 3m, 12H, ArH). nmax
3®lm): 3000 3br, NH, CH), 1569 3CvN), 1473, 1410,
1326, 1162, 1132, 1094, 983,826 and 749 cm21. m/z3%)
364 3M1, 2), 345 38), 260 325), 175 360), 160 320), 144
375), 130 342), and 111 3100).
1.2.8. C-22-Pyrrolo)-N-[2-240-chlorophenylsulphonamido)-
ethyl]nitrone 231). Obtained as colourless needles from
ethyl acetate 3433 mg, 53%), mp 164.5±1668C. 3Found: C,
47.7; H, 4.35; N, 13.0, S, 9.65. C13H13ClN3O3S requires: C,
47.8; H, 4.05; N, 12.9, S, 9.8%); d: 3.37 3q, J5.2Hz, 2H,
CH2NH), 3.90 3t, J4.9 Hz, 2H, CH2N1), 6.30, 6.46 and
6.97 3d, t, J3.0 Hz, 3H, pyrrole H), 6.90 3t, J6.0 Hz,
1H, NH), 7.45 and 7.85 32£d, J8.0 Hz, 2£2H, ArH), and
11.70 3br, 1H, pyrrole NH). nmax 3®lm): 3375 3br, NH), 3030
3br, CH), 2800 3br, NH), 1621 3CvN), 1585, 1476, 1423,
1.3. General procedure for the 1,3-dipolar cycloaddition
of nitrones
The nitrone 30.3 mmol) was taken up in dry xylene 320 ml)
and the dipolarophile 30.33 mmol) added. The mixture was
heated to 1208C for 16 h, cooled and xylene removed under
reduced pressure. The residue was puri®ed by column
chromatography on kieselgel, eluting with 1:1 v/v petro-
leum ether±ethyl acetate, followed by crystallisation from